Dow Wolff Cellulosics delivers high-performance cellulose derivatives and companion chemistries used for formulations across a broad variety of applications in the Food & Nutrition and Pharmaceutical  markets.  Our goal is to tailor polymer chemistry, morphology, and blending into solutions that enable our customers to provide consumers healthier outcomes.  In Modified Release, our research is targeted towards enabling formulators and manufacturing teams to address the regulatory and sustainability initiatives from dosage form development through commercialization.  Focus areas include modeling the performance design space to better predict structure-property relationships enabling enhanced Quality-by-Design, the development of materials that can deliver direct compression which can reduce processing and energy consumption costs by as much as 30%, and improved technologies for Osmotic Delivery Systems.   In Immediate Release, recent developments in low viscosity HPMC polymers and their applications to improve product performance and sustainability vs. conventional methods in coatings, capsules, and granulation will be discussed.

Health by design: Dow Wolff cellulosics excipient innovations for the pharmaceutical industry

244th National Meeting (2012)

The official archive and repository for all ACS Meetings & Expositions abstracts and select posters or presentations.